These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21847068)
1. European respiratory society/american thoracic society/international association for the study of lung cancer international multidisciplinary classification of lung adenocarcinoma: state of the art. Witt C J Thorac Oncol; 2011 Aug; 6(8):1451. PubMed ID: 21847068 [No Abstract] [Full Text] [Related]
2. [Recommendation concerning the microscopic classification of lung adenocarcinoma presented by International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society]. Langfort R; Szołkowska M Pneumonol Alergol Pol; 2012; 80(2):99-100. PubMed ID: 22370977 [No Abstract] [Full Text] [Related]
3. [Changes in classiffication of primary lung adenocarcinoma according to reccomendations of International Association for the Study of Lung Cancer/ /American Thoracic Society/European Respiratory Society]. Szołkowska M; Langfort R; Szczepulska-Wójcik E; Maksymiuk B Pneumonol Alergol Pol; 2012; 80(2):163-71. PubMed ID: 22370986 [No Abstract] [Full Text] [Related]
4. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859 [TBL] [Abstract][Full Text] [Related]
5. [Comments on International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma (2011)]. Huang SF Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):793-6. PubMed ID: 22336202 [No Abstract] [Full Text] [Related]
6. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification. Rodriguez EF; Monaco SE; Dacic S Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma. Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994 [TBL] [Abstract][Full Text] [Related]
8. Rare subtypes of adenocarcinoma of the lung. Ou SH; Kawaguchi T; Soo RA; Kitaichi M Expert Rev Anticancer Ther; 2011 Oct; 11(10):1535-42. PubMed ID: 21999127 [TBL] [Abstract][Full Text] [Related]
9. Performance validation in anatomic pathology: successful integration of a new classification system into the practice setting using the updated lung non-small cell carcinoma recommendations. Murugan P; Stevenson ME; Hassell LA Arch Pathol Lab Med; 2014 Jan; 138(1):105-9. PubMed ID: 24377817 [TBL] [Abstract][Full Text] [Related]
10. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Van Schil PE; Asamura H; Rusch VW; Mitsudomi T; Tsuboi M; Brambilla E; Travis WD Eur Respir J; 2012 Feb; 39(2):478-86. PubMed ID: 21828029 [TBL] [Abstract][Full Text] [Related]
11. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification]. Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740 [TBL] [Abstract][Full Text] [Related]
12. [The new classification of lung adenocarcinomas according to the American Thoracic Society and the European Respiratory Society: new recommendations to improve management]. Mlika M; Ayadi-Kaddour A; Boudaya S; Laabidi S; Boussen H; El Mezni F Tunis Med; 2013 May; 91(5):293-9. PubMed ID: 23716320 [TBL] [Abstract][Full Text] [Related]
13. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors. Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med; 1997 Jul; 156(1):320-32. PubMed ID: 9230769 [No Abstract] [Full Text] [Related]
15. [Small biopsies and cytologic specimens management in microscopic diagnosis and subtyping of non-small cell lung cancer, as recommended by IASLC/ATS/ERS]. Langfort R; Szołkowska M; Szczepulska-Wójcik E; Maksymiuk B Pneumonol Alergol Pol; 2012; 80(2):172-7. PubMed ID: 22370987 [No Abstract] [Full Text] [Related]
16. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China. Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970 [TBL] [Abstract][Full Text] [Related]
17. Genes and pathology of non-small cell lung carcinoma. Sakashita S; Sakashita M; Sound Tsao M Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579 [TBL] [Abstract][Full Text] [Related]
19. The new classification of lung adenocarcinomas: implications for pathologists and radiologists. Weynand B; Cohen J; Delos M; Fervaille C; Michoud M; Nollevaux MC; Reymond E; Ferretti GR JBR-BTR; 2013; 96(3):112-7. PubMed ID: 23971165 [TBL] [Abstract][Full Text] [Related]
20. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma. Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]